ARID2 and neoplasm: Several pathogenic gene mutations, including TP53 R175Pfs*2, ARID2 T1167Lfs*6, BRCA1 S1563C, and BRCA1 E1562Q, were observed to be shared by the patient’s cSCC tumor and the cSCC-PDX tumors.